Speakers: Mark Clements, MD, PhD

Mark Clements, MD, PhD

Endocrinologist; Associate Professor of Pediatrics
University of Missouri-Kansas City School of Medicine

 

Dr. Mark Clements, MD, PhD is an Associate Professor of Pediatrics, University of Missouri-Kansas City School of Medicine, Children’s Mercy Hospitals, Kansas City, MO. Dr. Clements is director of endocrine/diabetes research at Children’s Mercy, medical director for the Pediatric Clinical Research Unit at Children’s Mercy, co-PI of the TrialNet clinical center at Children’s Mercy, Pediatric Chair of the U.S. Type 1 Dabetes Exchange clinic network, and and serves as one of the data science leaders for the T1D Exchange Quality Improvement Network. Dr Clements’ research interests include studying “big data in type 1 diabetes (including electronic health records data, national and international registry data), understanding the relationship between glucose variability and diabetes-related complications, the identification of novel predictors of risk for diabetes-related complications, prevention of type 1 diabetes (through participation in TrialNet), the use of advanced machine learning and natural language processing to quality-improve type 1 diabetes care, the development of mHealth/digital health interventions to improve type 1 diabetes care, and health system interventions to promote data mobility in type 1 diabetes care. He is principal invesigator on co-investigator on 4 NIH awards, and is currently funded by the Helmsley Charitable Trust evaluate the impact of predictive analytis using advanced machine learning and natural language processing on diabetes care. He serves as a Member of Medical Advisory Board at Glooko, Inc, and an advisor to Eli Lilly. Dr. Clements has a passion for data analytics and insights to his pediatric endocrinology practice at Children’s Mercy Hospitals and is known as a passionate innovator for the children he treats. He completed his Pediatric Endocrinology fellowship at Children’s Mercy Hospital in Kansas City. Dr. Clements began his training in the Medical Scientist Training Program; he received his medical degree and PhD in Developmental Neuroscience from the Washington University Medical School in St. Louis, MO